Autoinducing Peptide I trifluoroacetate salt

Names

[ CAS No. ]:
200010-29-3

[ Name ]:
Autoinducing Peptide I trifluoroacetate salt

[Synonym ]:
L-Threoninamide, L-tyrosyl-L-seryl-N-[(3S,6S,9S,12S,15R)-12-(carboxymethyl)-6-[(1S)-1-methylpropyl]-3-[2-(methylthio)ethyl]-2,5,8,11,14-pentaoxo-9-(phenylmethyl)-1-thia-4,7,10,13-tetraazacyclohexadec-15-yl]-
L-Tyrosyl-L-seryl-N-{(3S,6S,9S,12S,15R)-9-benzyl-6-[(2S)-2-butanyl]-12-(carboxymethyl)-3-[2-(methylsulfanyl)ethyl]-2,5,8,11,14-pentaoxo-1-thia-4,7,10,13-tetraazacyclohexadecan-15-yl}-L-threoninamide

Biological Activity

[Description]:

Autoinducing Peptide I is a cyclic octapeptide secreted by Staphylococcus aureus and can be used in vaccine research[1].

[Related Catalog]:

Research Areas >> Infection
Signaling Pathways >> Others >> Others

[References]

[1]. Daly SM, et al. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation. Sci Rep. 2017 Apr 4;7(1):637.

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
1434.3±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C43H60N8O13S2

[ Molecular Weight ]:
961.112

[ Flash Point ]:
821.2±34.3 °C

[ Exact Mass ]:
960.372131

[ LogP ]:
0.23

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.641

Related Compounds